129 related articles for article (PubMed ID: 10621892)
1. Omeprazole and excessive sweating, if unrecognised, may lead to unnecessary investigations.
Mamun M; Caddick S; Siddiqi MA
Postgrad Med J; 1999 Nov; 75(889):701-2. PubMed ID: 10621892
[No Abstract] [Full Text] [Related]
2. Omeprazole and excessive sweating.
Prescrire Int; 2001 Apr; 10(52):51. PubMed ID: 11718160
[No Abstract] [Full Text] [Related]
3. A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy.
Alqutub AN; Masoodi I
Ger Med Sci; 2010 Sep; 8():. PubMed ID: 20930929
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole and nephritis.
Shuster J
Nursing; 2000 Oct; 30(10):79. PubMed ID: 11096979
[No Abstract] [Full Text] [Related]
5. Omeprazole in oesophageal reflux disease.
Dawson R; Manson JM
Lancet; 2000 Nov; 356(9243):1770-1. PubMed ID: 11095286
[No Abstract] [Full Text] [Related]
6. Acute kidney injury following proton pump inhibitor therapy.
Brewster UC; Perazella MA
Kidney Int; 2007 Mar; 71(6):589-93. PubMed ID: 17164832
[No Abstract] [Full Text] [Related]
7. Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Neal K; Logan R
Aliment Pharmacol Ther; 2001 Jul; 15(7):1085-6. PubMed ID: 11421886
[No Abstract] [Full Text] [Related]
8. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
Wang L; Zhou L; Lin S; Hu H; Xia J
J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
Armstrong D
Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
[No Abstract] [Full Text] [Related]
10. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
Wong WM; Wong BC; Hung WK; Yee YK; Yip AW; Szeto ML; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Lam SK
Gut; 2002 Oct; 51(4):502-6. PubMed ID: 12235071
[TBL] [Abstract][Full Text] [Related]
11. Recurrent anaphylaxis linked to pantoprazole.
Kollmeier AP; Eddleston J; Zuraw BL; Christiansen SC
J Allergy Clin Immunol; 2004 Oct; 114(4):975-7. PubMed ID: 15480345
[No Abstract] [Full Text] [Related]
12. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
[TBL] [Abstract][Full Text] [Related]
14. Clinical inquiries. Is the long-term use of proton pump inhibitors safe?
Malaty W; Stigleman S; Mayer J; Guthmann RA
J Fam Pract; 2004 Sep; 53(9):740-2. PubMed ID: 15353165
[No Abstract] [Full Text] [Related]
15. Asymptomatic giardiasis--an association with proton pump inhibitors?
Mukherjee S
Am J Gastroenterol; 2000 Dec; 95(12):3666-7. PubMed ID: 11151928
[No Abstract] [Full Text] [Related]
16. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Doornebal J; Bijlsma R; Brouwer RM
Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors.
Scully C
Br Dent J; 2010 Feb; 208(4):147. PubMed ID: 20186183
[No Abstract] [Full Text] [Related]
18. Anaphylactic reactions to proton-pump inhibitors.
Natsch S; Vinks MH; Voogt AK; Mees EB; Meyboom RH
Ann Pharmacother; 2000 Apr; 34(4):474-6. PubMed ID: 10772433
[TBL] [Abstract][Full Text] [Related]
19. [Photodistributed cutaneous drug reaction induced by proton pump inhibitors].
Raison-Peyron N; Minh HB; Peyron JL; Demoly P; Guillot B
Therapie; 2005; 60(1):85-7. PubMed ID: 15929479
[No Abstract] [Full Text] [Related]
20. Marked increase in gastric acid secretory capacity after omeprazole treatment.
Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
